Novel indolylmaleimide acts as GSK-3β inhibitor in human neural progenitor cells

被引:44
作者
Schmoele, Anne-Caroline [1 ]
Brennfuehrer, Anne [2 ]
Karapetyan, Gnuni [2 ]
Jaster, Robert [3 ]
Pews-Davtyan, Anahit [2 ]
Huebner, Rayk [1 ]
Ortinau, Stefanie [1 ]
Beller, Matthias [2 ]
Rolfs, Arndt [1 ]
Frech, Moritz J. [1 ]
机构
[1] Univ Rostock, Ctr Mental Hlth, Albrecht Kossel Inst Neuroregenerat AKos, D-18147 Rostock, Germany
[2] Univ Rostock, Leibniz Inst Katalyse eV, D-18059 Rostock, Germany
[3] Univ Rostock, Dept Internal Med 2, Div Gastroenterol, D-18057 Rostock, Germany
关键词
beta-Catenin; GSK-3; inhibitors; Indolylmaleimides; Human neural progenitor cells; ReNcell VM cell; GLYCOGEN-SYNTHASE KINASE-3; SMALL-MOLECULE INHIBITORS; FLUORINE; PROLIFERATION; DIFFERENTIATION; EXPRESSION; REGULATOR; PATHWAYS; NEURONS; ANALOGS;
D O I
10.1016/j.bmc.2010.07.045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wnt pathway is involved in cellular processes linked to either proliferation or differentiation. Therefore small molecules offer an attractive opportunity to modulate this pathway, whereas the key enzyme GSK-3 beta is of special interest. In this study, non-symmetrically substituted indolylmaleimides have been synthesized and their ability to function as GSK-3 beta inhibitors has been investigated in a human neural progenitor cell line. Among the newly synthesized compounds, the substance IM-12 showed a significant activity in several biological tests which was comparable or even outplayed the effects of the known GSK-3 beta inhibitor SB-216763. Furthermore the treatment of human neural progenitor cells with IM-12 resulted in an increase of neuronal cells. Therefore we conclude that indolylmaleimides act via the canonical Wnt signalling pathway by inhibition of the key enzyme GSK-3 beta. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6785 / 6795
页数:11
相关论文
共 62 条
[1]   β-Catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone [J].
Adachi, Kazuhide ;
Mirzadeh, Zaman ;
Sakaguchi, Masanori ;
Yamashita, Toru ;
Nikolcheva, Tania ;
Gotoh, Yukiko ;
Peltz, Gary ;
Gong, Leyi ;
Kawase, Takeshi ;
Alvarez-Buylla, Arturo ;
Okano, Hideyuki ;
Sawamoto, Kazunobu .
STEM CELLS, 2007, 25 (11) :2827-2836
[2]   A high throughput luminescent assay for glycogen synthase kinase-3β inhibitors [J].
Baki, Andrea ;
Bielik, Attila ;
Molnar, Laszlo ;
Szendrei, Gyorgyi ;
Keseru, Gyorgy M. .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (01) :75-83
[3]  
Bgu J.-P., 2008, Bioorganic and Medicinal Chemistry of Fluorine
[4]   Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin αvβ3 [J].
Boger, DL ;
Goldberg, J ;
Silletti, S ;
Kessler, T ;
Cheresh, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (07) :1280-1288
[5]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[6]   Catalytic and Stoichiometric Synthesis of Novel 3-Aminocarbonyl-, 3-Alkoxycarbonyl-, and 3-Amino-4-indolylmaleimides [J].
Brennfuehrer, Anne ;
Neumann, Helfried ;
Pews-Davtyan, Anahit ;
Beller, Matthias .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2009, 2009 (01) :38-42
[7]  
BUILLONS LC, 1998, CURR OPIN ONCOL, V10, P81
[8]   GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons [J].
Castelo-Branco, G ;
Rawal, N ;
Arenas, E .
JOURNAL OF CELL SCIENCE, 2004, 117 (24) :5731-5737
[9]  
Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO
[10]  
2-7